Back to Results
First PageMeta Content
Anatomy / Rheumatology / Rheumatoid arthritis / Disease-modifying antirheumatic drug / Osteoarthritis / Tofacitinib / Peter K. Gregersen / Health / Medicine / Arthritis


Downloaded from http://ard.bmj.com/ on November 25, [removed]Published by group.bmj.com 290 REVIEW Early referral recommendation for newly diagnosed
Add to Reading List

Open Document

File Size: 223,37 KB

Share Result on Facebook

City

Leeds / Leiden / Oxford / Philadelphia / Erlangen / Wakefield / /

Company

Bombardier / IgG / Australian Multicentre Clinical Trial Group / Moder KG / Medline / /

Continent

Europe / /

Country

Germany / Netherlands / France / Austria / United States / United Kingdom / /

/

Event

Product Issues / /

Facility

The American College of Rheumatology / Leiden University Medical Centre / University of Leeds School / University of Erlangen-Nuremberg / American College of Rheumatology / René Descartes University / University of Vienna / University of Colorado / /

IndustryTerm

referral tool / controlled magnetic resonance imaging study / treatment for early RA Study design Mean disease / magnetic resonance imaging / prevention of structural damage early in the disease / referral algorithm / treatment for patients with early RA and disease / imaging / dual-energy x-ray absorptiometry measurement / online article / literature search / /

MedicalCondition

early untreated rheumatoid arthritis / Rheumatism / mean disease / early inflammatory stages / inflammatory arthritis / special early arthritis / active inflammation / arthritis / early arthritis / early onset rheumatoid arthritis / non-inflammatory joint diseases / early inflammatory arthritis / rheumatoid arthritis / early rheumatoid arthritis / non-Hodgkin’s lymphoma / benign disease / persistent disease / early disease / rheumatoid arthritis benefit / fatigue / inflammatory joint diseases / definite and probable disease / early RA Study design Mean disease / early arthritis clinics / early onset arthritis / RA whose disease / specialty arthritis / acute phase inflammation / ctive rheumatoid arthritis / onset rheumatoid arthritis / early disease modifying antirheumatic drug / disease / increased disease / median disease / early inflammatory soft tissue / Asymptomatic synovitis / high disease / HLA-Dw14 positive High disease / Hannonen P. Only high disease / progressive disease / undifferentiated polyarthritis / symmetrical synovitis / osteoarthritis / disease modifying antirheumatic drugs / active disease / mild rheumatoid arthritis / untreated / chronic inflammation / synovitis / clinically manifest arthritis / month study Mean disease / infection / active rheumatoid arthritis / renal failure / inflammation / joint pain / inflammatory polyarthritis / months’ disease / /

Organization

University of Colorado / Denver / University of Vienna / Vienna / René Descartes University / Paris / American Rheumatism Association / Leiden University Medical Centre / Department of Rheumatology and Rehabilitation / University of Leeds School of Medicine / University of Erlangen-Nuremberg / American College of Rheumatology / Department of Rheumatology / /

Person

Nell V / Arch Intern / Ann Intern Med / Ann Rheum Dis / Salmon M. Early / Ann Rheum / Raynaud / /

Position

Walker / Author / physician for this condition / Professor / Fisher / Houtman PM / /

Product

sulindac / sulfasalazine / naproxen / Ibuprofen / prednisone / DV / joints / /

ProvinceOrState

Colorado / /

RadioStation

Gestel AM / Walker AM / /

Technology

x-ray / ultrasound / 1 Early referral algorithm / MRI / magnetic resonance imaging / genotype / /

URL

http /

SocialTag